Therapeutic effects of mesenchymal stem cells on renal ischemia-reperfusion injury: A matter of genetic transfer?

Accumulating evidence indicates that the protective effect of mesenchymal stem cells in models of tissue injury is related to the endocrine/pcrine release of factors. The delivery of growth factors, cytokines, prostaglandins, enzymes or extracellular vesicles from mesenchymal stem cells to target cells may induce cell reprogramming and de novo expression of factors involved in tissue proliferation and repair. A recent paper showed that Wharton jelly-derived mesenchymal stem cells interact with injured renal tubular epithelial cells, inducing the expression of native and foreign hepatocyte growth factor necessary for renal repair and fibrogenesis inhibition. The genetic exchange between resident and mesenchymal stem cells, probably mediated through microvesicles, therefore appears instrumental in mesenchymal stem cell therapeutic effects

Serum-epidemiological survey in a group of illegal immigrates for the evaluation of immunity against vaccine-preventable diseases in Italy

Background During the period May 2004 – December 2005 a serum epidemiological survey for preventable diseases through compulsory vaccination in Italy (diphtheria, tetanus, poliovirus, hepatitis B) and rubella in women was performed in a group of adult and illegal immigrants living in Rome, to evaluate the relationship between vaccination coverage and socio-demographic characteristics. Methods It was carried out by Elisa test (for rubella, tetanus, diphtheria and hepatitis B) and by neutralizing antibody titration (Poliovirus). Both descriptive analyses (calculation of mean, median, standard deviation, percentage) and inferential statistics (hypothesis tests) were used. Results Six hundred and sixty-seven immigrants were invited to participate and 318 of them performed the analysis (participation rate = 47.6 %). The percentages of immunized individuals were: 39.1% for diphtheria (basic immunization 59.3%), 74.8% for tetanus, 74.1% for poliomyelitis, and 94.7% for rubella. Only 2.8% was vaccinated against hepatitis B. Conclusion Most immigrants would need a booster dose for diphtheria and tetanus. Among Eastern European subjects Poliovirus vaccination coverage was lower than 70%, implying that the maintenance of high levels of it is strongly necessary. With regard to rubella, African women had the lowest coverage (87.5%) and their young age exposes to congenital rubella. Over half of immigrants were healthy carriers for HBV

Role of ncRNAs in modulation of liver fibrosis by extracellular vesicles

Abstract Extracellular vesicles (EVs) are small membrane vesicles carrying bioactive lipids, proteins and nucleic acids of the cell of origin. In particular, EVs carry non-coding RNAs (ncRNAs) and the vesicle membrane may protect them from degradation. Once released within the extracellular space, EVs can transfer their cargo, including ncRNAs, to neighboring or distant cells, thus inducing phenotypical and functional changes that may be relevant in several physio-pathological conditions. This review provides an overview of the role of EV-carried ncRNAs in the modulation of liver fibrosis. In particular, we focused on EV-associated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) involved into the development of liver fibrosis and on the potential use of EV-associated ncRNAs as diagnostic and prognostic biomarkers of liver fibrosis

Extracellular vesicles in renal tissue damage and regeneration

AbstractExtracellular vesicles (EVs) appear as important actors in cell-to-cell communication. EV content is characterized by proteins and RNA species that dynamically reflect cell and tissue state. Urinary EVs in particular may act in inter-nephron communication with possible beneficial or detrimental effects. Increasing interest is addressed to the pharmacological properties of EVs as a cell-free therapy, since several of the effects crAQ/tgqcedited to stem cells have been recapitulated by administration of their EVs. Preclinical data in models of renal damage indicate a general regenerative potential of EVs derived from mesenchymal stromal cells of different sources, including bone marrow, fetal tissues, urine and kidney. In this review we will discuss the results on the effect of EVs in repair of acute and chronic renal injury, and the mechanisms involved. In addition, we will analyse the strategies for EV pharmacological applications in renal regenerative medicine and limits and benefits involved

A high-power and fast charging Li-ion battery with outstanding cycle-life

Electrochemical energy storage devices based on Li-ion cells currently power almost all electronic devices and power tools. The development of new Li-ion cell configurations by incorporating innovative functional components (electrode materials and electrolyte formulations) will allow to bring this technology beyond mobile electronics and to boost performance largely beyond the state-of-the-art. Here we demonstrate a new full Li-ion cell constituted by a high-potential cathode material, i.e. LiNi0.5Mn1.5O4, a safe nanostructured anode material, i.e. TiO2, and a composite electrolyte made by a mixture of an ionic liquid suitable for high potential applications, i.e. Pyr1,4PF6, a lithium salt, i.e. LiPF6, and standard organic carbonates. The final cell configuration is able to reversibly cycle lithium for thousands of cycles at 1000 mAg-1 and a capacity retention of 65% at cycle 2000. © 2017 The Author(s)

Italian contribution to University Autonomy in Kazakhstan: the Erasmus+ project “Transition to University Autonomy in Kazakhstan” (TRUNAK)

University autonomy is the capacity of universities to be self-governin

Nanoporous carbons from hydrothermally treated biomass as anode materials for lithium ion batteries

Biomass is transformed to carbon nanoparticles with surface-end groups called ‘hydrochar’ (HC) by an efficient and green hydrothermal carbonization (HTC) method. Three different approaches are used to introduce porosity to the HC: sole heat treatment, traditional potassium hydroxide (KOH) activation, and environmentally benign magnesium oxide (MgO) templating. All the resulting microporous materials are tested as Li-ion intercalation hosts in lithium cells by using an 1 M LiPF6 in EC/DMC electrolyte solution. They all show stable reversible capacities at elevated current rates (1C), closely comparable to the maximum theoretical capacity of graphite. Among all the materials studied, the HC-MA with a surface area of 150 m2 g1 and obtained by MgO templating of the hydrochar shows the best cycling performance in lithium cell at room temperature (307 mAh g1 at cycle 100 at 1C). The HC-600 with the highest degree of aromaticity/order, lowest content of oxygen functional groups and surface area of 250 m2 g1, obtained by heating the hydrochar at 600 C under inert atmosphere, shows the best power and overall performance with its ability to sustain high discharge/charge rates (1C, 2C, 5C, 10C, 20C). These electrochemical performances attained with materials of reasonable specific surface areas – obtained by green, low cost and practical strategies – can address the space limitations in Li-ion battery applications by improving volumetric energy densities

Improving basic skills in celiac-like disease diagnosis. A case report

Background: The diagnosis of Coeliac disease (CD) requires a combination of sign/symptoms, positivity of specific antibodies and duodenal histological evidence of villous atrophy. Duodenal villous atrophy, despite representing the CD landmark, is not specific since it is found in many gastrointestinal disorders. Giardiasis is one of the most common human intestinal protozoan infestations in industrialized countries whose histological duodenal mucosa damage could mimic that of CD. The present report shows how a wise clinical and laboratory assessment led us shortly to a correct diagnosis. Case presentation: A 42-year-old outpatient woman without previous significant gastrointestinal diseases, was referred with dyspeptic symptoms, fatigue and mild diarrhea from 4 months. Her first investigations including immunoglobulin A (IgA) anti-tissue transglutaminase antibodies (anti-tTG) and stool parasitological and cultural analysis were negative. An esophagogastroduodenoscopy (EGDS) showed no mucosal alteration. But histology demonstrated a Helicobacter Pylori (HP) pan-gastritis while duodenal mucosa showed villous atrophy consistent with a diagnosis of CD Marsh type 3b. While on gluten-free diet (GFD) the patient didn't experience any improvement of symptoms. Duodenal biopsies were then reviewed showing the presence of trophozoites of Giardia on the luminal surface of the duodenal wall and at the same time, a second stool examination revealed the presence of trophozoites and cysts of Giardia. Treated with metronidazole, 500 mg twice daily for 6 days the patient reduced diarrhea after few days. After about 2 months of GFD she was invited to discontinue it. At the same time stool examination was repeated with negative results. She subsequently performed eradication for Hp with triple therapy (Pylera®). Around 6 months later, the patient did not complain any gastrointestinal symptoms. Serological tests were normal and at a follow-up EGDS, duodenal mucosa had normal histology with normal finger-like villi and absence of Giardia trophozoites. Conclusion: This case report shows how CD diagnosis can sometimes be manifold. Intestinal villous atrophy alone may not automatically establish a diagnosis of CD. In the present case the clinical scenario could be fully explained by giardiasis. Indeed, different diagnostic tools and a multi-step approaches have been used to determine the final correct diagnosis